French Guiana Wellness Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Wellness Network.

Press releases published on October 16, 2026

5 hours ago

Leading Gel Pen Assembly Machine Manufacturers in China 2026: Driving Pen Assembly Innovation

Indeterminate EIN Presswire

11 hours ago

Outlook for the Medical Device Flexible Printed Circuits Market Improves Driven by Increasing Global Demand

Indeterminate EIN Presswire

11 hours ago

Medical Device Contract Design and Engineering Market Size, Share, Trends, Growth and Forecast to 2030

Indeterminate EIN Presswire

12 hours ago

Global Medical Device Contract Micro-Molding Market Expected to Exceed $2.7 Billion by 2030

Indeterminate EIN Presswire

12 hours ago

Global Medical Balloon Manufacturing Market Size, Share, Trends, Growth and Forecast to 2030

Indeterminate EIN Presswire

12 hours ago

Lubricious Medical Device Coatings Market Size, Trends, Share and Growth Forecast 2030

Indeterminate EIN Presswire

an hour ago

OXB Appoints Joachim Kreuzburg as Independent Non-Executive Director

Indeterminate GlobeNewswire

an hour ago

Libtayo® (cemiplimab) Recommended for EU Approval by the CHMP for Updated Dosing Regimen Across All Approved Cancer Types

Indeterminate GlobeNewswire

an hour ago

Tango Therapeutics to Present Updated Vopimetostat + RAS(ON) Combination Data at European Society For Medical Oncology (ESMO) Congress 2026

Indeterminate GlobeNewswire

an hour ago

Fractyl Health's Revita Meets Six-Month Co-Primary Endpoint in Ongoing REMAIN-1 Pivotal Study, With Highly Statistically Significant Reduction in Weight Regain After GLP-1 Discontinuation

Indeterminate GlobeNewswire

an hour ago

Adial Pharmaceuticals Appoints David Rubenstein, M.D., Ph.D., as Chief Scientist to Advance its Colon-Targeted AhR Agonist, AT177, for Ulcerative Colitis

Indeterminate GlobeNewswire

an hour ago

Tiziana Doses Last Patient in Phase 2 Trial of Intranasal Foralumab for Mild Alzheimer’s Disease

Indeterminate GlobeNewswire

5 hours ago

Senturi Pharma announces exclusive European distribution agreement for PERTZYE®

Indeterminate GlobeNewswire

5 hours ago

Three Orelabrutinib Studies Presented in Oral Sessions at the 88th Annual Meeting of the Japanese Society of Hematology

Indeterminate GlobeNewswire

6 hours ago

Microbiotica Raises £36 Million ($48 Million) in Series C Financing to Advance Pipeline into Phase 2 Clinical Development

Indeterminate GlobeNewswire

7 hours ago

Leads Biolabs' Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Enrolls First Patient in Phase Ib/II Combination Trial in Metastatic Colorectal Cancer

Indeterminate GlobeNewswire

9 hours ago

City Therapeutics Announces Pricing of Upsized Initial Public Offering

Indeterminate GlobeNewswire